Janumet^™: a combination product suitable for use in patients with Type 2 diabetes

Author： Reynolds Jonathan Kent Neumiller Joshua J Campbell R Keith

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.10, 2008-10, pp. : 1559-1565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

By Chwieduk Claudine M.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 349-361

Adis International

Access to resources Recommend Favorite

Combination lipid therapy in type 2 diabetes mellitus

By Vergèès Bruno

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Sitagliptin/metformin fixed-dose combination: a guide to its use in type 2 diabetes mellitus

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Saxagliptin: A Review of its Use as Combination Therapy in the Management of Type 2 Diabetes Mellitus in the EU

By Yang Lily P.H.

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 229-248

Adis International

Access to resources Recommend Favorite

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

By Rosenson Robert Carlson Dawn Kelly Maureen Setze Carolyn Hirshberg Boaz Stolzenbach James Williams Laura

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 47-57

Springer Publishing Company

Access to resources Recommend Favorite